Gene · 8405
Papers2,215
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 2,215
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Harnessing the E3 ligase SPOP for targeted degradation of the NUP98::KDM5A fusion oncoprotein. | Cell Rep | 2025 | 41307993 | PubTator, text mining | PubMed |
| Liquid-Liquid Phase Separation: Mechanisms, Roles, and Implications in Cellular Function and Disease. | FASEB Bioadv | 2025 | 41268324 | PubTator, text mining | PubMed |
| Histone methyltransferase KMT2D targets the SPOP-G3BP1 axis to enhance AR stability and drive castration-resistant prostate cancer progression. | Mol Biomed | 2025 | 41247636 | PubTator, text mining | PubMed |
| SPOP and MMR/MSI alterations in prostate cancer: relationship with PD-L1, TILs and AR expression. | Pathologica | 2025 | 41243500 | PubTator, text mining | PubMed |
| Hepatitis B virus X protein promotes the progression and immune escape of hepatocellular carcinoma by activating KLF16-C12orf49-PD-L1 axis. | Oncogene | 2025 | 41238928 | PubTator, text mining | PubMed |
| O-GlcNAcylation of SPOP regulates colorectal cancer progression and ferroptosis by mediating β-catenin degradation. | Cell Death Discov | 2025 | 41213915 | PubTator, text mining | PubMed |
| Talazoparib Monotherapy in Metastatic Castration-resistant Prostate Cancer with DNA Damage Response Alterations-Genomic Features Associated with Response to Therapy. | Eur Urol Oncol | 2025 | 41173779 | PubTator, text mining | PubMed |
| Correction: Endometrial cancer (EC) derived G3BP1 overexpression and mutant promote EC tumorigenesis and metastasis via SPOP/ERα axis. | Cell Commun Signal | 2025 | 41137013 | PubTator, text mining | PubMed |
| Investigating Genomic Differences by Ethnicity in Breast, Colorectal and Prostate Cancers: Secondary Data Analysis of the Genomic Data Commons (GDC) Database. | Cancer Med | 2025 | 41134550 | PubTator, text mining | PubMed |
| SPOP mediates apoptosis and protects against necroptosis by regulating ubiquitination of RIPK1 and RIPK3. | JCI Insight | 2025 | 41122967 | PubTator, text mining | PubMed |
| CircLRBA Promotes Epithelial-Mesenchymal Transition, Immune Evasion, Chemoimmunotherapy Resistance and Metastasis Through Stabilizing Twist1. | Adv Sci (Weinh) | 2025 | 41082269 | PubTator, text mining | PubMed |
| Correction: Phosphorylation-dependent regulation of SPOP by LIMK2 promotes castration-resistant prostate cancer. | Br J Cancer | 2025 | 41068489 | PubTator, text mining | PubMed |
| Evaluating sensitivity of NGS-based mutation detection across diverse sample types in prostate cancer. | Diagn Pathol | 2025 | 41029752 | PubTator, text mining | PubMed |
| Deep Sequencing Reveals Novel Mutations in Androgen Receptor-Related Genes in Prostate Cancer. | Int J Mol Sci | 2025 | 41009328 | PubTator, text mining | PubMed |
| A graph neural network-based approach for predicting SARS-CoV-2-human protein interactions from multiview data. | PLoS One | 2025 | 40997149 | PubTator, text mining | PubMed |
| Bridging the Gap: PSMA Radioligand Therapy for Asian Men with Prostate Cancer. | Nucl Med Mol Imaging | 2025 | 40979134 | PubTator, text mining | PubMed |
| Targeting lysosomal protease CTSL promotes anti-tumor immunity and sensitizes HNSCC to PD-1 blockade by stabilizing PDK1 and activating Akt-PD-L1 axis. | Neoplasia | 2025 | 40961907 | PubTator, text mining | PubMed |
| SNX7 mediates inhibition of autophagy in prostate cancer via activation of CFLIP expression. | Discov Oncol | 2025 | 40883630 | PubTator, text mining | PubMed |
| Bladder Cancer: Role of Circular RNAs in Oncogenesis, Tumor Suppression, and Therapeutic Target Identification. | Cancer Genomics Proteomics | 2025 | 40883021 | PubTator, text mining | PubMed |
| BUB1-based risk model predicts prostate cancer prognosis and reveals therapeutic vulnerabilities. | Eur J Med Res | 2025 | 40859340 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8405/papers?page=5